CDR2 and ovarian carcinoma: The detection of anti-cdr2 antibodies in ovarian cancer can be improved by in vitro transcription–translation (ITT) of radiolabelled cdr2 protein and immunoprecipitation assay (Monstad et al. 2006; Eichler et al. 2013).